Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug recall
Pharma
Merck's GLP-1 play; Astellas' AAV deal—Fierce Pharma Asia
Merck licensed an oral GLP-1 from Hansoh. Astellas tapped Sangamo's brain-penetrating AAV. Betta's lung cancer med won an FDA approval. And more.
Angus Liu
Dec 20, 2024 8:51am
Citing labeling glitch, Endo expands clonazepam recall
Nov 19, 2024 1:52pm
AZ China fallout, Pfizer's $1B plan in China—Fierce Pharma Asia
Nov 8, 2024 8:54am
B. Braun and Baxter launch separate drug recalls in the US
Aug 15, 2024 7:30am
Hikma extends recall of pain drug, reports adverse event
Jul 23, 2024 1:12pm
Glenmark recalls 114 lots of low potassium drug in the US
Jun 25, 2024 10:40am